PS-B02-4: GLYCINE BETAINE ALLEVIATES MYOCARDIAL HYPERTROPHY IN SPONTANEOUS HYPERTENSION RATS BY REGULATING AMPK/NF-KAPPAB/STIM1/ORAI1 SIGNALING PATHWAY

Bing Xiao,Yan Zhao,Xiuchun Yang,Jingchao LU
DOI: https://doi.org/10.1097/01.hjh.0000914440.61878.90
IF: 4.9
2023-01-01
Journal of Hypertension
Abstract:Spontaneous hypertension is one of the common cardiovascular diseases. Glycine betaine (GB) is a natural vitamin that has the potential to lower blood pressure. This work attempted to investigate the precise mechanism of action of GB in spontaneous hypertension. Spontaneous hypertension rats (SHRs) were administrated with 100, 200 or 400 mg/kg of GB by gavage, or followed by injection of lentivirus-mediated STIM1 overexpression vector. The heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP) and heart weight/body weight (HW/BW) of rats were monitored. The pathological changes of myocardium were examined by hematoxylin and eosin staining and Masson staining. The expression of gene and protein was detected by quantitative real-time PCR and western blotting. GB at 200 and 400 mg/kg reduced the levels of HR, SBP, DBP and HW/BW in SHRs. GB decreased the cross-sectional area and fibrotic area in the myocardium, and down-regulated the expression of ANP and beta-MHC in the myocardium of SHRs. It indicated that GB treatment effectively alleviated myocardial hypertrophy in SHRs. Additionally, GB treatment enhanced p-AMPK expression and repressed the expression of p-NF-kappaB, STIM1 and Orai1 in the myocardium of SHRs. STIM1 overexpression reversed GB treatment-mediated inhibition of myocardial hypertrophy in SHRs. This study demonstrated that GB activated AMPK and repressed NF-kappaB/STIM1/Orai1 signaling pathway, which contributed to alleviate myocardial hypertrophy in SHRs. Thus, this work provides a theoretical basis for GB as an antihypertensive drug.
peripheral vascular disease
What problem does this paper attempt to address?